To further validate and expand these studies, we tried to define the mechanism by which PDLIM2/STAT3 signaling controls the pulmonary recruitment of blood monocytes, the prerequisite for AM expansion and lung cancer promotion. Here, STAT3 is linked to lung carcinoma.